Literature DB >> 9520092

Effects of high-lipase pancreatin on fecal fat, neutral sterol, bile acid, and short-chain fatty acid excretion in patients with pancreatic insufficiency resulting from chronic pancreatitis.

T Nakamura1, Y Tandoh, A Terada, N Yamada, T Watanabe, A Kaji, K Imamura, H Kikuchi, T Suda.   

Abstract

CONCLUSIONS: Steatorrhea was almost completely stopped and malabsorption of neutral sterols and short-chain fatty acids was reduced by treatment of high-lipase pancreatin in Japanese patients with pancreatic insufficiency whose dietary fat consumption is low.
METHODS: Fifteen patients with chronic pancreatitis complicated by steatorrhea who consumed an average of 48 g of dietary fats a day were selected as subjects and given 3 g of high-lipase pancreatin (lipase, 379,800 USP U/g), at each meal (total daily dose is 9 g) for a mean duration of 28.5 d. Fecal output and fecal fat neutral sterol, bile acid, and short-chain fatty acid excretion were determined before and after the course of pancreatin therapy.
RESULTS: Pancreatin administration resulted in significant reductions (P < 0.01) in fecal output (from 243.2 to 149.1 g), excretion of fecal fat, (from 12.3 to 3.9 g), animal sterols (from 816.3 to 604.6 mg), and short-chain fatty acids (from 52.6 to 18.5 mM). In contrast, no marked changes were recorded in fecal excretion of beta-sitosterol (a plant sterol), bile acids, or the hydroxy fatty acid fraction. Fecal fat and short-chain fatty-acid excretion showed strong correlations with fecal output.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9520092     DOI: 10.1007/bf02787504

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  33 in total

1.  Physico-chemical state of lipids in intestinal content during their digestion and absorption.

Authors:  A F HOFMANN; B BORGSTROM
Journal:  Fed Proc       Date:  1962 Jan-Feb

2.  No negative feedback regulation between plasma CCK levels and luminal tryptic activities in patients with pancreatic insufficiency.

Authors:  T Nakamura; K Takebe; K Kudoh; M Ishii; K Imamura; H Kikuchi; F Kasai; Y Tandoh; N Yamada; Y Arai
Journal:  Int J Pancreatol       Date:  1995-02

3.  Fecal excretions of hydroxy fatty acid and bile acid in diabetic diarrheal patients.

Authors:  T Nakamura; K Imamura; F Kasai; F Tsushima; H Kikuchi; K Takebe
Journal:  J Diabetes Complications       Date:  1993 Jan-Mar       Impact factor: 2.852

4.  Effect of intrajejunal acidity on aqueous phase bile acid and lipid concentrations in pancreatic steatorrhoea due to cystic fibrosis.

Authors:  P L Zentler-Munro; W J Fitzpatrick; J C Batten; T C Northfield
Journal:  Gut       Date:  1984-05       Impact factor: 23.059

5.  The effect of starch malabsorption on fecal short-chain fatty acid excretion in man.

Authors:  W Scheppach; C Fabian; M Sachs; H Kasper
Journal:  Scand J Gastroenterol       Date:  1988-08       Impact factor: 2.423

6.  Pancreatic enzyme replacement: the effect of antacids or cimetidine.

Authors:  D Y Graham
Journal:  Dig Dis Sci       Date:  1982-06       Impact factor: 3.199

7.  Effect of cimetidine on enzyme inactivation, bile acid precipitation, and lipid solubilisation in pancreatic steatorrhoea due to cystic fibrosis.

Authors:  P L Zentler-Munro; D R Fine; J C Batten; T C Northfield
Journal:  Gut       Date:  1985-09       Impact factor: 23.059

8.  Cholesterol malabsorption in pancreatic insufficiency: effects of enzyme substitution.

Authors:  M Vuoristo; H Väänänen; T A Miettinen
Journal:  Gastroenterology       Date:  1992-02       Impact factor: 22.682

9.  Starch digestion in normal subjects and patients with pancreatic disease, using a 13CO2 breath test.

Authors:  M Hiele; Y Ghoos; P Rutgeerts; G Vantrappen
Journal:  Gastroenterology       Date:  1989-02       Impact factor: 22.682

10.  Influence of dietary fiber on fecal excretion of volatile fatty acids by human adults.

Authors:  S E Fleming; M A Rodriguez
Journal:  J Nutr       Date:  1983-08       Impact factor: 4.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.